Khong Y. Ng

GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells

Eric L. Smith, Kim Harrington, Reed Masakayan et al. · Science Translational Medicine · 2019 · 385 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader–Willi syndromes

Stormy J. Chamberlain, Pin-Fang Chen, Khong Y. Ng et al. · Proceedings of the National Academy of Sciences · 2010 · 321 citations

Life Sciences, Genetics, Molecular Biology +17

Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma

Carlos Fernández de Larrea, Andrea V. Lopez, Khong Y. Ng et al. · Blood Cancer Discovery · 2020 · 214 citations · Full text

Life Sciences, Immunology, Oncology +17

Optimal Dual-Targeted CAR Construct Simultaneously Targeting Bcma and GPRC5D Prevents Bcma-Escape Driven Relapse in Multiple Myeloma

Carlos Fernández de Larrea, Andrea V. Lopez, Yunxin Chen et al. · Blood · 2019 · 23 citations

Medicine, Cancer Biology, Oncology +14